Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Buzz on the Bullboards: Who Has Emerged from COVID the Strongest?

(Image via Ivanhoe Mines Ltd.) Are we about to see the global economy fully open up and recover, or are we headed for more trouble with new lockdowns and virus variants? The COVID-19 pandemic has played havoc with global stocks for more than a year, but since it...

It Can Take a Lifetime to Build a Good Company, But Only a Minute to Ruin

(Challenger 350 interior image via Bombardier Inc.) Much like that Will Rogers quote that is all too real, even these days … The world is trying to get as close to a “pre-pandemic” norm as it can and nowhere is this movement more evident than i...

XPhyto: Why Rapid PCR Testing is Here to Stay

Regular coronavirus testing is destined to become the norm for many years to come, regardless of how many people get vaccinated against COVID-19. So says Hugh Rogers, the CEO of XPhyto Therapeutics Corp. ( CSE: XPHY ) (FSE: 4XT) ( OTC: XPHYF ) , a Canadian life scie...

XPhyto: Buyouts, Biosensors and a Booming Business

Test, test, test! It’s the World Health Organization’s battle cry in the global war against COVID-19 and other coronaviruses – including future outbreaks. And it is not getting any less resonant as new variants continue to cause ha...

Buzz on the Bullboards: 2021 The Year of the Cannabis Comeback?

(TAAT CEO, Setti Coscarella. Image via TAAT Lifestyle & Wellness Ltd.) If you look at one set of market headlines around COVID-19, you would read about stimulus packages, vaccine rollouts, and a general lightening in sentiment … but if you look news outlets, you see...

Buzz on the Bullboards: Who’s Hot in Energy, Tech, & Cannabis

(Via @Recon_Africa on Twitter.) From short-term healthcare bets to long-term energy plays, and the swings of the cannabis market, small-cap investors have had their hands full keeping up with the markets in 2021. The latest hot stock has co...

Buzz on the Bullboards: Stocks Making the Most of the Summer

(Image via Inter Pipeline Ltd.) After a few tumultuous weeks of see-sawing market performances on Bay Street and Wall Street, it would appear as if companies were working to get on track to get back to the seasonably busy fall months and shake off these COVID restri...

Buzz on the Bullboards: Six More Weeks of Volatility?

If you haven’t heard, the groundhog saw his shadow, and if the snowfall on the East and West coasts weren’t enough of an indication, it looks like winter may be with us for awhile still … along with COVID and its variants, which are still a...

Nov 27th 2019, Silver Chartbook: Risk less – trade more

Risk less – trade more Once a speculator has an established edge he/she has two ways of increasing profitability. Frequency = exposing the edge more often. Size = trade larger. It depends on ones psychology, ones system and many more factors to select one of those two rout...

InMed Shares Trade Up 25% After Becoming First to Advance Cannabinol into Clinical Trials

InMed Pharmaceuticals shares traded 25% higher after reporting that it is the first to advance cannabinol into therapeutic clinical trials. Vancouver-based clinical stage biopharmaceutical company InMed Pharmaceuticals Inc. (IN:TSX; IMLFF:OTCQX) , which is engaged in...
1 2 3